Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

69.96
Delayed Data
As of Aug 18
 +0.11 / +0.16%
Today’s Change
55.06
Today|||52-Week Range
75.04
+11.72%
Year-to-Date

Today’s Trading

Previous close69.85
Today’s open69.52
Day’s range69.47 - 70.44
Volume4,016,367
Average volume (3 months)5,398,476
Market cap$111.5B
Dividend yield3.66%
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.62%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+12.16%
P/E ratio17.2
Price/Sales3.98
Price/Book24.03

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.11+0.23%
CELGCelgene+0.07+0.05%
GSKGlaxoSmithKline-0.30-0.77%
BMYBristol-Myers Squibb-0.35-0.62%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.38
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts